| Year |
Citation |
Score |
| 2019 |
Holtan SG, Shabaneh A, Betts BC, Rashidi A, MacMillan ML, Ustun C, Amin K, Vaughn BP, Howard J, Khoruts A, Arora M, DeFor TE, Johnson D, Blazar BR, Weisdorf DJ, ... Wang J, et al. Stress responses, M2 macrophages, and a distinct microbial signature in fatal intestinal acute graft-versus-host disease. Jci Insight. 5. PMID 31393854 DOI: 10.1172/Jci.Insight.129762 |
0.318 |
|
| 2019 |
Zhang J, Wang J, Marzese DM, Wang X, Yang Z, Li C, Zhang H, Zhang J, Chen CC, Kelly DF, Hua W, Hoon DSB, Mao Y. B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 30914782 DOI: 10.1038/S41374-019-0238-5 |
0.36 |
|
| 2019 |
Schefter AM, Uppendahl LD, Zhang Y, Wang J, Shetty M, Clark C, Grad A, Mullany SA, Winterhoff B, Starr T. Single cell RNA-sequencing identifies unique immune cell profiles across metastatic sites in a case of primary ovarian cancer Gynecologic Oncology. 154: 44. DOI: 10.1016/J.Ygyno.2019.04.105 |
0.302 |
|
| 2018 |
Winterhoff B, Talukdar S, Chang Z, Wang J, Starr TK. Single-cell sequencing in ovarian cancer: a new frontier in precision medicine. Current Opinion in Obstetrics & Gynecology. PMID 30507625 DOI: 10.1097/Gco.0000000000000516 |
0.302 |
|
| 2018 |
Giles KM, Rosenbaum BE, Berger M, Izsak A, Li Y, Illa Bochaca I, Vega-Saenz de Miera E, Wang J, Darvishian F, Zhong H, Osman I. Revisiting the clinical and biologic relevance of partial PTEN loss in melanoma. The Journal of Investigative Dermatology. PMID 30148988 DOI: 10.1016/J.Jid.2018.07.031 |
0.355 |
|
| 2018 |
Sarver AL, Mills L, Temiz N, Scott M, Sarver A, Spector L, Wang J, Breen M, Subramanian S, Moriarity B, Modiano J, Largaespada D. Abstract 3399: Comparative genomic analyses of osteosarcoma etiology reveal a chromosomal structural rationale for the increased incidence of osteosarcoma in dogs Cancer Research. 78: 3399-3399. DOI: 10.1158/1538-7445.Am2018-3399 |
0.329 |
|
| 2016 |
Paoluzzi L, Hanniford D, Sokolova E, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma. Cancer Medicine. PMID 27169980 DOI: 10.1002/Cam4.667 |
0.347 |
|
| 2016 |
Saliba J, Evensen NA, Meyer J, Dolgalev I, Newman D, Chowdhury A, Nersting J, Wang J, Schmiegelow K, Carroll WL. Using Whole Exome Sequencing in Pediatric Acute Lymphoblastic Leukemia Germline, Diagnosis, and Relapse Trios to Discover Novel Relapse Enriched Mutations for Clonal Backtracking By Ddpcr Blood. 128: 4085-4085. DOI: 10.1182/Blood.V128.22.4085.4085 |
0.347 |
|
| 2015 |
Wu X, Deng F, Li Y, Daniels G, Du X, Ren Q, Wang J, Wang LH, Yang Y, Zhang V, Zhang D, Ye F, Melamed J, Monaco ME, Lee P. ACSL4 promotes prostate cancer growth, invasion and hormonal resistance. Oncotarget. PMID 26636648 DOI: 10.18632/Oncotarget.6438 |
0.336 |
|
| 2015 |
Bhatla T, Dandekar S, Lu BY, Wang J, Han E, Bitterman D, Jones CL, Evensen NA, Magid M, Meyer JA, Carroll WL. Genomic Characterization of Poorly Differentiated Neuroendocrine Carcinoma in a Pediatric Patient. Journal of Pediatric Hematology/Oncology. PMID 26558807 DOI: 10.1097/Mph.0000000000000463 |
0.32 |
|
| 2015 |
Wang J, Hua W, Huang SK, Fan K, Takeshima L, Mao Y, Hoon DS. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb. Oncotarget. PMID 26334503 DOI: 10.18632/Oncotarget.5030 |
0.356 |
|
| 2015 |
Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Evensen NA, Bride K, Waanders AJ, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar S, Park E, et al. MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia. Blood. PMID 26324703 DOI: 10.1182/Blood-2015-04-639138 |
0.336 |
|
| 2015 |
Jensen TW, Ray T, Wang J, Li X, Naritoku WY, Han B, Bellafiore F, Bagaria SP, Qu A, Cui X, Taylor CR, Ray PS. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay. Journal of the National Cancer Institute. 107. PMID 26041837 DOI: 10.1093/Jnci/Djv148 |
0.301 |
|
| 2015 |
Salhi A, Farhadian JA, Giles KM, Vega-Saenz de Miera E, Silva IP, Bourque C, Yeh K, Chhangawala S, Wang J, Ye F, Zhang DY, Hernando-Monge E, Houvras Y, Osman I. RSK1 activation promotes invasion in nodular melanoma. The American Journal of Pathology. 185: 704-16. PMID 25579842 DOI: 10.1016/J.Ajpath.2014.11.021 |
0.333 |
|
| 2015 |
Marzese DM, Liu M, Huynh JL, Hirose H, Donovan NC, Huynh KT, Kiyohara E, Chong K, Cheng D, Tanaka R, Wang J, Morton DL, Barkhoudarian G, Kelly DF, Hoon DS. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome. Pigment Cell & Melanoma Research. 28: 82-93. PMID 25169209 DOI: 10.1111/Pcmr.12307 |
0.319 |
|
| 2015 |
Salhi A, Farhadian JA, Giles KM, Miera ECVd, Silva IPD, Bourque C, Yeh K, Chhangawala S, Wang J, Ye F, Zhang DY, Hernando-Monge E, Houvras Y, Osman I. Abstract A14: Hyperactivation of RSK1 is a hallmark of metastatic nodular melanoma Cancer Research. 75. DOI: 10.1158/1538-7445.Mel2014-A14 |
0.338 |
|
| 2015 |
Paoluzzi L, Hanniford D, Sokolova E, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. Abstract 3522: BET and BRAF inhibitors act synergistically against BRAF mutant melanoma Cancer Research. 75: 3522-3522. DOI: 10.1158/1538-7445.Am2015-3522 |
0.353 |
|
| 2015 |
Giles K, Li Y, Salhi A, Wang J, Robinson E, Osman I. Abstract 2164: Revisiting the mechanisms of PTEN loss in melanoma Cancer Research. 75: 2164-2164. DOI: 10.1158/1538-7445.Am2015-2164 |
0.385 |
|
| 2014 |
Feng M, Bao Y, Li Z, Li J, Gong M, Lam S, Wang J, Marzese DM, Donovan N, Tan EY, Hoon DS, Yu Q. RASAL2 activates RAC1 to promote triple-negative breast cancer progression. The Journal of Clinical Investigation. 124: 5291-304. PMID 25384218 DOI: 10.1172/Jci76711 |
0.313 |
|
| 2014 |
Vitanza NA, Zaky W, Blum R, Meyer JA, Wang J, Bhatla T, Morrison DJ, Raetz EA, Carroll WL. Ikaros deletions in BCR-ABL-negative childhood acute lymphoblastic leukemia are associated with a distinct gene expression signature but do not result in intrinsic chemoresistance. Pediatric Blood & Cancer. 61: 1779-85. PMID 24976218 DOI: 10.1002/Pbc.25119 |
0.354 |
|
| 2014 |
Jones CL, Bhatla T, Blum R, Wang J, Paugh SW, Wen X, Bourgeois W, Bitterman DS, Raetz EA, Morrison DJ, Teachey DT, Evans WE, Garabedian MJ, Carroll WL. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model. The Journal of Biological Chemistry. 289: 20502-15. PMID 24895125 DOI: 10.1074/Jbc.M114.569889 |
0.308 |
|
| 2014 |
Martin L, Grigoryan A, Wang D, Wang J, Breda L, Rivella S, Cardozo T, Gardner LB. Identification and characterization of small molecules that inhibit nonsense-mediated RNA decay and suppress nonsense p53 mutations. Cancer Research. 74: 3104-13. PMID 24662918 DOI: 10.1158/0008-5472.Can-13-2235 |
0.313 |
|
| 2014 |
Marzese DM, Scolyer RA, Huynh JL, Huang SK, Hirose H, Chong KK, Kiyohara E, Wang J, Kawas NP, Donovan NC, Hata K, Wilmott JS, Murali R, Buckland ME, Shivalingam B, et al. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis. Human Molecular Genetics. 23: 226-38. PMID 24014427 DOI: 10.1093/Hmg/Ddt420 |
0.33 |
|
| 2014 |
Paoluzzi L, Hanniford D, Sokolova E, Dolgalev I, Heguy A, Osman I, Darvishian F, Wang J, Bradner JE, Hernando E. Preclinical testing supports combined BET and BRAF inhibition as a promising therapeutic strategy for melanoma. Journal of Clinical Oncology. 32: 9072-9072. DOI: 10.1200/Jco.2014.32.15_Suppl.9072 |
0.305 |
|
| 2014 |
Jones CL, Gearheart CM, Fosmire S, Delgado-Martin C, Pais F, Wang J, Bhatla T, Bitterman DS, de Rijk SR, Bourgeois W, Dandekar SC, Raetz EA, Hermiston ML, Garabedian MJ, Porter CC, et al. MAPK Signaling Cascades Mediate Distinct Glucocorticoid Resistance Mechanisms in Pediatric B-Precursor ALL Blood. 124: 789-789. DOI: 10.1182/Blood.V124.21.789.789 |
0.364 |
|
| 2014 |
Bhatla T, Blum R, Wang J, Jones CL, Morrison DJ, Raetz EA, Burke MJ, Brown P, Harvey RC, Willman CL, Loh M, Hunger SP, Carroll WL. Deciphering the Epigenetic Landscape of Relapsed Pediatric Acute Lymphoblastic Leukemia Blood. 124: 612-612. DOI: 10.1182/Blood.V124.21.612.612 |
0.345 |
|
| 2013 |
Wu X, Li Y, Wang J, Wen X, Marcus MT, Daniels G, Zhang DY, Ye F, Wang LH, Du X, Adams S, Singh B, Zavadil J, Lee P, Monaco ME. Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer. Plos One. 8: e77060. PMID 24155918 DOI: 10.1371/Journal.Pone.0077060 |
0.333 |
|
| 2013 |
Meyer JA, Wang J, Hogan LE, Yang JJ, Dandekar S, Patel JP, Tang Z, Zumbo P, Li S, Zavadil J, Levine RL, Cardozo T, Hunger SP, Raetz EA, Evans WE, et al. Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia. Nature Genetics. 45: 290-4. PMID 23377183 DOI: 10.1038/Ng.2558 |
0.312 |
|
| 2013 |
Bhatla T, Wang J, Bourgeois W, Danielle BS, Raetz EA, Morrison DJ, Teachey DT, Michael G, Carroll WL. Deletions In TBL1XR1 Results In Glucocorticoid Resistance By Decreasing Glucocorticoid Signaling In Childhood B-Lymphoblastic Leukemia Blood. 122: 602-602. DOI: 10.1182/Blood.V122.21.602.602 |
0.336 |
|
| 2012 |
Bhatla T, Wang J, Morrison DJ, Raetz EA, Burke MJ, Brown P, Carroll WL. Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia. Blood. 119: 5201-10. PMID 22496163 DOI: 10.1182/Blood-2012-01-401687 |
0.331 |
|
| 2012 |
Wang J, Ray PS, Sim MS, Zhou XZ, Lu KP, Lee AV, Lin X, Bagaria SP, Giuliano AE, Cui X. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling. Oncogene. 31: 4798-802. PMID 22249250 DOI: 10.1038/Onc.2011.635 |
0.333 |
|
| 2012 |
Meyer J, Wang J, Hogan LE, Patel J, Tang Z, Zumbo P, Li S, Zavadil J, Levine RL, Cardozo T, Hunger S, Raetz EA, Morrison DJ, Mason C, Carroll WL. Relapse-specific mutations in cytosolic 5’-nucleotidase II in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology. 30: 9507-9507. DOI: 10.1200/Jco.2012.30.15_Suppl.9507 |
0.317 |
|
| 2011 |
Hogan LE, Meyer JA, Yang J, Wang J, Wong N, Yang W, Condos G, Hunger SP, Raetz E, Saffery R, Relling MV, Bhojwani D, Morrison DJ, Carroll WL. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood. 118: 5218-26. PMID 21921043 DOI: 10.1182/Blood-2011-04-345595 |
0.336 |
|
| 2011 |
Ray PS, Bagaria SP, Wang J, Shamonki JM, Ye X, Sim MS, Steen S, Qu Y, Cui X, Giuliano AE. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study. Annals of Surgical Oncology. 18: 3839-47. PMID 21424368 DOI: 10.1245/S10434-011-1657-8 |
0.315 |
|
| 2011 |
Rose AE, Poliseno L, Wang J, Clark M, Pearlman A, Wang G, Vega Y Saenz de Miera EC, Medicherla R, Christos PJ, Shapiro R, Pavlick A, Darvishian F, Zavadil J, Polsky D, Hernando E, et al. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Research. 71: 2561-71. PMID 21343389 DOI: 10.1158/0008-5472.Can-10-2958 |
0.347 |
|
| 2011 |
Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, Huang P, Martens JW, Giuliano AE, Zhang N, Cheng NH, et al. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. The Journal of Clinical Investigation. 121: 212-25. PMID 21123948 DOI: 10.1172/Jci43144 |
0.347 |
|
| 2011 |
Bhatla T, Morrison DJ, Wang J, Raetz EA, Burke M, Brown P, Carroll WL. Epigenetic Modulation Leads to Re-Expression of Relapse Specific Silenced Genes and Induces Chemosensitivity in Childhood Acute Lymphoblastic Leukemia (ALL), Blood. 118: 3455-3455. DOI: 10.1182/Blood.V118.21.3455.3455 |
0.352 |
|
| 2010 |
Ray PS, Wang J, Qu Y, Sim MS, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DS, Walter MA, Martens JW, Richardson AL, Giuliano AE, Cui X. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Research. 70: 3870-6. PMID 20406990 DOI: 10.1158/0008-5472.Can-09-4120 |
0.33 |
|
| 2010 |
Wang J, Kuiatse I, Lee AV, Pan J, Giuliano A, Cui X. Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation. Molecular Cancer Research : McR. 8: 266-77. PMID 20145041 DOI: 10.1158/1541-7786.Mcr-09-0221 |
0.337 |
|
| 2010 |
Hogan LE, Mason C, Meyer J, Wang J, Tang Z, Brown S, Morrison DJ, Hunger S, Raetz EA, Carroll WL. High throughput transcriptome sequencing of pediatric relapsed acute lymphoblastic leukemia (ALL). Journal of Clinical Oncology. 28: 9521-9521. DOI: 10.1200/Jco.2010.28.15_Suppl.9521 |
0.348 |
|
| 2010 |
Bhatla T, Wang J, Morrison DJ, Zaky WT, Raetz EA, Carroll WL. Vorinostat Reverses Relapse-Specific Drug Resistance Gene Expression Signatures In Childhood Acute Lymphoblastic Leukemia (ALL). Blood. 116: 3630-3630. DOI: 10.1182/Blood.V116.21.3630.3630 |
0.352 |
|
| 2010 |
Meyer JA, Hogan LE, Wang J, Yang JJ, Patel J, Levine RL, Hunger SP, Raetz E, Mason C, Carroll WL. High Throughput Transcriptome Sequencing of Pediatric Relapsed Acute Lymphoblastic Leukemia (ALL) Identifies Relapse Specific Mutations and Expression Blood. 116: 3233-3233. DOI: 10.1182/Blood.V116.21.3233.3233 |
0.359 |
|
| 2010 |
Wang J, Ray P, Qu Y, Sim M, Shamonki J, Bagaria S, Ye X, Liu B, Walter M, Hoon D, Giuliano A, Cui X. Abstract 3742: FOXC1 is a potential prognostic marker with functional significance in basal-like breast cancer Cancer Research. 70: 3742-3742. DOI: 10.1158/1538-7445.Am10-3742 |
0.351 |
|
| 2010 |
Qu Y, Wang J, Shin-Sim M, Huang J, Liu B, Zhang N, Cui Y, Giuliano AE, Cheng N, Cui X. Abstract 1794: TXNL2 is a key regulator of reactive oxygen species levels and NF-κB activity in cancer cells Cancer Research. 70: 1794-1794. DOI: 10.1158/1538-7445.Am10-1794 |
0.353 |
|
| 2009 |
Zhang DY, Ye F, Gao L, Liu X, Zhao X, Che Y, Wang H, Wang L, Wu J, Song D, Liu W, Xu H, Jiang B, Zhang W, Wang J, et al. Proteomics, pathway array and signaling network-based medicine in cancer. Cell Division. 4: 20. PMID 19863813 DOI: 10.1186/1747-1028-4-20 |
0.306 |
|
| 2009 |
Qu Y, Wang J, Sim MS, Liu B, Giuliano A, Barsoum J, Cui X. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Research and Treatment. 121: 311-21. PMID 19609669 DOI: 10.1007/S10549-009-0470-6 |
0.332 |
|
| 2009 |
Wolf LV, Yang Y, Wang J, Xie Q, Braunger B, Tamm ER, Zavadil J, Cvekl A. Identification of pax6-dependent gene regulatory networks in the mouse lens. Plos One. 4: e4159. PMID 19132093 DOI: 10.1371/Journal.Pone.0004159 |
0.327 |
|
| 2009 |
Rabin KR, Wang J, Meyer J, Loudin MG, Bhojwani D, Morrison D, Devidas M, Heerema NA, Carroll AJ, Pession A, Basso G, Mullighan CG, Hunger SP, Carroll WL. Gene Expression Profiling in Down Syndrome Acute Lymphoblastic Leukemia Identifies Distinct Profiles Associated with CRLF2 Expression Status. Blood. 114: 2389-2389. DOI: 10.1182/Blood.V114.22.2389.2389 |
0.317 |
|
| 2009 |
Hogan L, Bhojwani D, Wang J, Morrison D, Yang JJ, Zhang Y, Zavadil J, Condos G, Hunger SP, Willman CL, Relling MV, Raetz E, Carroll WL. Up-Regulation of Genes Involved in Folate Metabolism Characterize Late but Not Early Relapse in Childhood Acute Lymphoblastic Leukemia. Blood. 114: 1733-1733. DOI: 10.1182/Blood.V114.22.1733.1733 |
0.314 |
|
| 2008 |
Bogunovic D, O'Neill D, Adams S, Wang J, Darvishian F, Pavlick AC, Shapiro RL, Zavadil J, Osman I, Bhardwaj N. Gene expression profile for metastatic melanoma and patient survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 9049. PMID 27950725 DOI: 10.1200/Jco.2008.26.15_Suppl.9049 |
0.31 |
|
| 2008 |
Yang JJ, Bhojwani D, Yang W, Cai X, Stocco G, Crews K, Wang J, Morrison D, Devidas M, Hunger SP, Willman CL, Raetz EA, Pui CH, Evans WE, Relling MV, et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. Blood. 112: 4178-83. PMID 18768390 DOI: 10.1182/Blood-2008-06-165027 |
0.343 |
|
| 2008 |
Rabin KR, Wang J, Tsimelzon A, Morrison D, Gaikwad AS, Hogan L, Rye CL, Hilsenbeck SG, Devidas M, Heerema NA, Carroll AJ, Basso G, Carroll WL, Pession A, Bhojwani D. Gene Expression Profiling Differentiates Childhood Acute Lymphoblastic Leukemia in Down Syndrome Versus Non-Down Syndrome Patients. Blood. 112: 1203-1203. DOI: 10.1182/Blood.V112.11.1203.1203 |
0.314 |
|
| 2006 |
Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Human Molecular Genetics. 15: 2490-508. PMID 16825284 DOI: 10.1093/Hmg/Ddl171 |
0.478 |
|
| 2006 |
Suzuki H, Zuo Y, Wang J, Zhang MQ, Malhotra A, Mayeda A. Characterization of RNase R-digested cellular RNA source that consists of lariat and circular RNAs from pre-mRNA splicing. Nucleic Acids Research. 34: e63. PMID 16682442 DOI: 10.1093/Nar/Gkl151 |
0.413 |
|
| 2005 |
Wang J, Smith PJ, Krainer AR, Zhang MQ. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Research. 33: 5053-62. PMID 16147989 DOI: 10.1093/Nar/Gki810 |
0.46 |
|
| 2005 |
Xuan Z, Zhao F, Wang J, Chen G, Zhang MQ. Genome-wide promoter extraction and analysis in human, mouse, and rat. Genome Biology. 6: R72. PMID 16086854 DOI: 10.1186/Gb-2005-6-8-R72 |
0.647 |
|
| 2003 |
Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Research. 31: 3568-71. PMID 12824367 DOI: 10.1093/Nar/Gkg616 |
0.462 |
|
| 2003 |
Xuan Z, Wang J, Zhang MQ. Computational comparison of two mouse draft genomes and the human golden path. Genome Biology. 4: R1. PMID 12537546 DOI: 10.1186/Gb-2002-4-1-R1 |
0.634 |
|
| Show low-probability matches. |